You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 12, December 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reduced Cerebral Blood Flow in Early Stages of Human Immunodeficiency Virus Infection

Eva Schielke, MD; Klaus Tatsch, MD; Hans Walter Pfister, MD; Claudia Trenkwalder, MD; Gerda Leinsinger, MD; Carl Martin Kirsch, MD; Alexander Matuschke, MD; Karl Max Einhäupl, MD

Arch Neurol. 1990;47(12):1342-1345.


Abstract

• In order to determine if brain perfusion abnormalities, which are known in patients with acquired immunodeficiency syndrome dementia, occur in early stages of human immunodeficiency virus infection, technetium 99m hexamethyl-propyleneamine oxime-single-photon emission computed tomography studies were performed in 20 patients infected with human immunodeficiency virus who belonged to Walter Reed stages I through IV. None of these patients demonstrated signs of dementia or severe neurological dysfunction. Pathological patterns of hexamethyl-propyleneamine oxime uptake were seen in 14 patients, seven of whom had normal results during neurological examination. Only four patients had signs of cerebral atrophy on cranial computed tomographic scan. These data suggest that subtle changes in cerebral perfusion seem to arise early in the course of human immunodeficiency virus infection and may indicate human immunodeficiency virus encephalopathy before neurological symptoms or noticeable structural damage occurs.



Author Affiliations

From the Departments of Neurology (Drs Schielke, Pfister, Trenkwalder, and Einhäupl) and Radiology, Division of Nuclear Medicine (Drs Tatsch, Leinsinger, and Kirsch), Klinikum Grosshadern; and the Department of Internal Medicine, Medizinische Poliklinik (Dr Matuschke), University of Munich (Federal Republic of Germany).


Footnotes

Accepted for publication May 11, 1990.

Reprint requests to Department of Neurology, Klinikum Grosshadern, University of Munich, Marchioninstrasse 15, 8000 Munich 70, Federal Republic of Germany (Dr Schielke).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Resting cerebral blood flow: A potential biomarker of the effects of HIV in the brain
Ances et al.
Neurology 2009;73:702-708.
ABSTRACT | FULL TEXT  

Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex
Chang et al.
Neurology 2000;54:389-389.
ABSTRACT | FULL TEXT  

Blood-Brain Barrier Tight Junction Disruption in Human Immunodeficiency Virus-1 Encephalitis
Dallasta et al.
Am. J. Pathol. 1999;155:1915-1927.
ABSTRACT | FULL TEXT  

Influence of Cognitive Reserve on Neuropsychological Functioning in Asymptomatic Human Immunodeficiency Virus-1 Infection
Stern et al.
Arch Neurol 1996;53:148-153.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.